We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNT icon
1601
RadNet
RDNT
$6.08B
$119K ﹤0.01%
3,530
ASTE icon
1602
Astec Industries
ASTE
$975M
$118K ﹤0.01%
1,870
BLNK icon
1603
Blink Charging
BLNK
$87.1M
$118K ﹤0.01%
+2,863
New +$106K
DON icon
1604
WisdomTree US MidCap Dividend Fund
DON
$4.11B
$118K ﹤0.01%
2,830
FARO
1605
DELISTED
Faro Technologies
FARO
$118K ﹤0.01%
1,514
GIII icon
1606
G-III Apparel Group
GIII
$1.43B
$118K ﹤0.01%
3,579
ICHR icon
1607
Ichor Holdings
ICHR
$2.67B
$118K ﹤0.01%
2,200
MYRG icon
1608
MYR Group
MYRG
$5.1B
$118K ﹤0.01%
1,295
-119
-8% -$9.68K
VRE
1609
DELISTED
Veris Residential
VRE
$118K ﹤0.01%
6,888
-724
-10% -$12.1K
ZION icon
1610
Zions Bancorporation
ZION
$10.5B
$118K ﹤0.01%
2,238
-277
-11% -$15.5K
JOE icon
1611
St. Joe Company
JOE
$3.89B
$117K ﹤0.01%
2,613
-215
-8% -$9.69K
PVH icon
1612
PVH
PVH
$3.77B
$117K ﹤0.01%
1,085
SGMO
1613
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$117K ﹤0.01%
9,803
DK icon
1614
Delek US
DK
$4.18B
$116K ﹤0.01%
5,349
+267
+5% +$6.03K
OCGN icon
1615
Ocugen
OCGN
$458M
$116K ﹤0.01%
+14,478
New +$122K
RGNX icon
1616
Regenxbio
RGNX
$704M
$116K ﹤0.01%
2,991
USPH icon
1617
US Physical Therapy
USPH
$1.24B
$116K ﹤0.01%
1,002
-102
-9% -$11.7K
XLI icon
1618
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$116K ﹤0.01%
1,141
-109
-9% -$11.2K
ATSG
1619
DELISTED
Air Transport Services Group
ATSG
$116K ﹤0.01%
5,010
TELL
1620
DELISTED
Tellurian Inc.
TELL
$116K ﹤0.01%
24,854
+10,733
+76% +$32.9K
DISCK
1621
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$116K ﹤0.01%
4,009
BKD icon
1622
Brookdale Senior Living
BKD
$3B
$115K ﹤0.01%
14,512
-1,122
-7% -$8.07K
DVA icon
1623
DaVita
DVA
$11.4B
$115K ﹤0.01%
957
-203
-18% -$24K
ECPG icon
1624
Encore Capital Group
ECPG
$2.15B
$115K ﹤0.01%
2,423
-219
-8% -$9.52K
IPGP icon
1625
IPG Photonics
IPGP
$3.57B
$115K ﹤0.01%
547

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.